Find stats on top websites
The health technology research industry is experiencing rapid innovation, driven by demand for more efficient and engaging research methodologies. Gamification and digital tools are gaining traction for participant recruitment, retention, and data collection, especially in clinical trials and behavioral studies. Increased focus on remote research and real-world data is shaping its growth and evolution.
Total Assets Under Management (AUM)
Clinical Trials Market Size in United States
~Approximately $25.5 billion (2024 estimate)
(5.7% CAGR)
- Driven by increasing R&D activities in pharma and biotech.
- Growing prevalence of chronic diseases.
- Rising demand for personalized medicine.
25.5 billion USD
AI algorithms can personalize game experiences and research tasks in real-time, optimizing engagement and data collection based on individual participant behavior and performance.
Seamlessly integrating data from wearable devices (e.g., smartwatches, fitness trackers) into gamified research can provide real-world physiological and behavioral data alongside cognitive and self-reported measures.
Utilizing blockchain technology can enhance data security, ensure data integrity, and provide transparent, immutable records for participant consent in decentralized research networks.
This program aims to streamline the regulatory review process for software as a medical device (SaMD) by assessing the developer's organizational excellence rather than product-by-product review.
While not directly impacting BMT's research enablement tools, its clients developing digital therapeutics (like Akili) could benefit, fostering a market more receptive to digital health solutions that may incorporate BMT's data collection methods. BMT would need to ensure data output from its games are compliant with guidelines for clinical decision support and SaMD if used by clients for such purposes.
HIPAA sets national standards to protect sensitive patient health information from being disclosed without the patient's consent or knowledge, including regulations on electronic transactions and data security.
BMT must ensure its platform and data handling processes are fully compliant with HIPAA regulations, especially when collecting identifiable health data for clinical trials, to maintain client trust and avoid legal penalties.
This act aims to accelerate medical product development and bring new innovations and advances to patients faster and more efficiently, including provisions for real-world evidence (RWE) and patient-focused drug development.
The emphasis on RWE and patient-focused development creates a strong demand for innovative data collection methods like BMT's gamified solutions, allowing researchers to gather richer, more ecologically valid data for regulatory submissions.
Sign up now and unleash the power of AI for your business growth